Balchem (NASDAQ:BCPC) Trading Down 85.6% - Time to Sell?

Balchem Co. (NASDAQ:BCPC - Get Free Report) shares were down 85.6% during trading on Monday . The stock traded as low as $160.66 and last traded at $23.26. Approximately 36,180 shares were traded during mid-day trading, a decline of 74% from the average daily volume of 140,526 shares. The stock had previously closed at $161.53.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on BCPC. Sidoti raised Balchem to a "hold" rating in a research report on Tuesday, February 25th. Wall Street Zen lowered Balchem from a "buy" rating to a "hold" rating in a report on Wednesday, May 21st. Finally, HC Wainwright set a $180.00 price target on Balchem and gave the stock a "buy" rating in a research report on Monday, April 28th.

Balchem Trading Down 0.9%

The company has a current ratio of 1.99, a quick ratio of 1.16 and a debt-to-equity ratio of 0.19. The company has a 50 day moving average of $162.92 and a 200 day moving average of $164.68. The firm has a market cap of $5.22 billion, a price-to-earnings ratio of 40.71, a price-to-earnings-growth ratio of 4.41 and a beta of 0.91.

Balchem (NASDAQ:BCPC - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The basic materials company reported $1.22 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.25 by ($0.03). The firm had revenue of $250.52 million for the quarter, compared to the consensus estimate of $245.70 million. Balchem had a net margin of 13.47% and a return on equity of 11.37%. The company's revenue for the quarter was up 4.5% on a year-over-year basis. During the same period in the prior year, the business earned $1.03 earnings per share. As a group, research analysts anticipate that Balchem Co. will post 4.64 EPS for the current year.

Hedge Funds Weigh In On Balchem

Institutional investors have recently bought and sold shares of the business. Compound Planning Inc. raised its holdings in shares of Balchem by 4.1% in the first quarter. Compound Planning Inc. now owns 1,789 shares of the basic materials company's stock valued at $297,000 after buying an additional 70 shares during the last quarter. Quadrant Capital Group LLC increased its holdings in shares of Balchem by 8.2% in the fourth quarter. Quadrant Capital Group LLC now owns 989 shares of the basic materials company's stock valued at $161,000 after purchasing an additional 75 shares in the last quarter. Covestor Ltd boosted its position in Balchem by 93.8% in the 4th quarter. Covestor Ltd now owns 157 shares of the basic materials company's stock valued at $26,000 after buying an additional 76 shares during the last quarter. Arizona State Retirement System increased its stake in shares of Balchem by 0.8% in the 4th quarter. Arizona State Retirement System now owns 9,413 shares of the basic materials company's stock valued at $1,534,000 after buying an additional 77 shares during the period. Finally, Vident Advisory LLC raised its position in shares of Balchem by 6.0% during the fourth quarter. Vident Advisory LLC now owns 1,421 shares of the basic materials company's stock worth $232,000 after acquiring an additional 80 shares during the last quarter. Institutional investors own 87.91% of the company's stock.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.